The EHC Think Tank receives external grant-based funding support from both public and private organisations. The Think Tank accepts financial and non-monetary support with the firm mutual understanding that the EHC Think Tank maintains full and complete independence at all times, and makes choices based exclusively on patients’ interests and needs. 

In 2023, the EHC Think Tank received hands-off grants from BioMarin, CSL Behring, Novo Nordisk, Pfizer, Roche, Sanofi, Sobi, and Takeda.

The 2023 Innovation Summit was kindly supported by BioMarin, Pfizer, and Sanofi.